Frontiers in Aging Neuroscience Aging Neuroscience Review Article

of neuronal structures and functions are well documented by the neuroscience community, what is less appreciated is the diverse response of brain neurons to stresses and adverse factors during aging or as a result of neurodegenerative diseases. A pronounced yet underappreciated phenomenon in the response of different neuronal populations to stressful neuro-degenerative conditions is the appearance of selective neuronal vulnerability (SNV). SNV refers to the differential sensitivity of neuronal populations in the CNS to stresses that cause cell injury or death and lead to neurodegeneration. For example, neurons in the entorhinal cortex, hippocampus CA1 region, frontal cortex , and amygdala are the populations of neurons most sensitive to the neurodegeneration associated with Alzheimer's disease In Parkinson's disease (PD), dopaminergic neurons of the substantia nigra are the primary neurons undergoing cell death And, amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of, primarily, spinal motor neurons, but also cortical and brain stem neurons (Rowland and Shneider, 2001). The fact that specifi c brain regions exhibit differential vulner-abilities to various neurodegenerative diseases is a refl ection of both the specifi city in the etiology of each disease and of the heterogeneity in neuronal responses to cell-damaging processes

[1]  M. Vreugdenhil,et al.  Calcium and normal brain ageing. , 2010, Cell calcium.

[2]  D. Surmeier,et al.  Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. , 2010, Cell calcium.

[3]  B. A. Reyes,et al.  Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates , 2010, Brain Research.

[4]  Z. Qin,et al.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.

[5]  M. Michaelis,et al.  Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress , 2009, BMC Neuroscience.

[6]  D. Praticò Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.

[7]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[8]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[9]  J. Stamler,et al.  Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.

[10]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[11]  E. Klann,et al.  Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type 3 and ERK. , 2008, Journal of neurophysiology.

[12]  J. Zimmermann,et al.  Reversible disulfide bond formation of intracellular proteins probed by NMR spectroscopy. , 2007, Free radical biology & medicine.

[13]  P. Reddy,et al.  Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. , 2007, Antioxidants & redox signaling.

[14]  D. Surmeier,et al.  Calcium, ageing, and neuronal vulnerability in Parkinson's disease , 2007, The Lancet Neurology.

[15]  Xue-wen Chen,et al.  Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampus. , 2007, Genomics.

[16]  T. Foster,et al.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain , 2007, Aging cell.

[17]  E. Klann,et al.  Calcium release by ryanodine receptors mediates hydrogen peroxide-induced activation of ERK and CREB phosphorylation in N2a cells and hippocampal neurons. , 2007, Cell calcium.

[18]  N. Schuff,et al.  Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T , 2007, Neurobiology of Aging.

[19]  R. Giffard,et al.  Selective Dysfunction of Hippocampal CA1 Astrocytes Contributes to Delayed Neuronal Damage after Transient Forebrain Ischemia , 2007, The Journal of Neuroscience.

[20]  M. Aschner,et al.  Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. , 2007, Toxicology.

[21]  Dwight C. German,et al.  Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease , 2007, Experimental Neurology.

[22]  L. Moran,et al.  The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability , 2007, Neurogenetics.

[23]  M. Starkey,et al.  Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease , 2007, Brain Research.

[24]  J. Langston,et al.  Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration , 2006, Neuroscience.

[25]  M. Cuénod,et al.  Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia , 2006, Neuroscience.

[26]  M. Segal,et al.  Control of neuronal plasticity by reactive oxygen species. , 2006, Antioxidants & redox signaling.

[27]  E. Klann,et al.  Sources and targets of reactive oxygen species in synaptic plasticity and memory. , 2006, Antioxidants & redox signaling.

[28]  J. Sanchez-Ramos,et al.  Neuroanatomical mapping of DNA repair and antioxidative responses in mouse brain: Effects of a single dose of MPTP. , 2006, Neurotoxicology.

[29]  J. Lincoln,et al.  Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro , 2006, Neuroscience Letters.

[30]  S. Ballinger,et al.  Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. , 2006, Circulation research.

[31]  W. Markesbery,et al.  DNA oxidation in Alzheimer's disease. , 2006, Antioxidants & redox signaling.

[32]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[33]  Shaharyar M. Khan,et al.  Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. , 2006, Current Alzheimer research.

[34]  C. Hidalgo Cross talk between Ca2+ and redox signalling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[35]  Maria Speranza Desole,et al.  Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway , 2005, Annals of the New York Academy of Sciences.

[36]  Xue-wen Chen,et al.  High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. , 2005, Brain research. Molecular brain research.

[37]  Ling Lin,et al.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. , 2005, Human molecular genetics.

[38]  J. Andersen,et al.  Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.

[39]  Andrei Rozov,et al.  Presynaptic Ca2+ dynamics, Ca2+ buffers and synaptic efficacy. , 2005, Cell calcium.

[40]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[41]  J. Cano,et al.  Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons , 2004, Journal of Neural Transmission.

[42]  Xiongwei Zhu,et al.  Mitochondrial failures in Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.

[43]  Eric Klann,et al.  Reactive oxygen species and synaptic plasticity in the aging hippocampus , 2004, Ageing Research Reviews.

[44]  C. B. Pickett,et al.  The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. , 2004, Free radical biology & medicine.

[45]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[46]  M. Segal,et al.  Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity , 2004, Molecular Neurobiology.

[47]  George Perry,et al.  Oxidative stress signalling in Alzheimer's disease , 2004, Brain Research.

[48]  Charles DeCarli,et al.  Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer’s disease , 2004, Neurobiology of Aging.

[49]  D. Ferrari,et al.  Calcium and apoptosis: facts and hypotheses , 2003, Oncogene.

[50]  Bente Pakkenberg,et al.  Aging of the human cerebellum: A stereological study , 2003, The Journal of comparative neurology.

[51]  M. Segal,et al.  Paradoxical Actions of Hydrogen Peroxide on Long-Term Potentiation in Transgenic Superoxide Dismutase-1 Mice , 2003, The Journal of Neuroscience.

[52]  T. Wieloch,et al.  Flow cytometric analysis of mitochondria from CA1 and CA3 regions of rat hippocampus reveals differences in permeability transition pore activation , 2003, Journal of neurochemistry.

[53]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[54]  G. Rotilio,et al.  Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals , 2003, Brain Research Bulletin.

[55]  T. Wieloch,et al.  Brain damage in a mouse model of global cerebral ischemia Effect of NMDA receptor blockade , 2003, Brain Research.

[56]  G. Tomasevic,et al.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.

[57]  C. Barnstable,et al.  Mitochondrial uncoupling protein 2 in the central nervous system: neuromodulator and neuroprotector. , 2003, Biochemical pharmacology.

[58]  T. Wieloch,et al.  Mitochondrial oxidative stress after global brain ischemia in rats , 2002, Neuroscience Letters.

[59]  E. Klann,et al.  Hippocampal memory and plasticity in superoxide dismutase mutant mice , 2002, Physiology & Behavior.

[60]  W. Streit Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.

[61]  K. Hensley,et al.  Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.

[62]  A. Godzik,et al.  Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation , 2002, Trends in Neurosciences.

[63]  F. Cardozo-Pelaez,et al.  Effects of diethylmaleate on DNA damage and repair in the mouse brain. , 2002, Free radical biology & medicine.

[64]  J. Langston,et al.  Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.

[65]  E. Klann,et al.  Potentiation of Hippocampal Synaptic Transmission by Superoxide Requires the Oxidative Activation of Protein Kinase C , 2002, The Journal of Neuroscience.

[66]  K. Davies,et al.  Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.

[67]  Hui Zhang,et al.  Co-culture with astrocytes or microglia protects metabolically impaired neurons , 2001, Mechanisms of Ageing and Development.

[68]  F. Aloisi Immune function of microglia , 2001, Glia.

[69]  D. Sanchís,et al.  Uncoupling protein 2 in the brain: distribution and function. , 2001, Biochemical Society transactions.

[70]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[71]  M. Smith,et al.  Chemistry and biochemistry of oxidative stress in neurodegenerative disease. , 2001, Current medicinal chemistry.

[72]  J. Obeso,et al.  Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease , 2001, Experimental Neurology.

[73]  W. Burke,et al.  Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.

[74]  T. Bates,et al.  Activation of murine microglial cell lines by lipopolysaccharide and interferon‐γ causes NO‐mediated decreases in mitochondrial and cellular function , 2001, The European journal of neuroscience.

[75]  M. Mishina,et al.  Real‐time, two‐dimensional visualization of ischaemia‐induced glutamate release from hippocampal slices , 2001, The European journal of neuroscience.

[76]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[77]  G. Barrionuevo,et al.  Impairment of Long-term Potentiation and Associative Memory in Mice That Overexpress Extracellular Superoxide Dismutase , 2000, The Journal of Neuroscience.

[78]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[79]  Rafael Yuste,et al.  From form to function: calcium compartmentalization in dendritic spines , 2000, Nature Neuroscience.

[80]  Masahiko Watanabe,et al.  Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain , 2000, Neuroscience Letters.

[81]  W. Markesbery,et al.  Decreased base excision repair and increased helicase activity in Alzheimer's disease brain , 2000, Brain Research.

[82]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[83]  K. McNaught,et al.  Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.

[84]  R. Nicoll,et al.  Long-term potentiation--a decade of progress? , 1999, Science.

[85]  R. Barouki,et al.  Repression of gene expression by oxidative stress. , 1999, The Biochemical journal.

[86]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[87]  T. Wieloch,et al.  Differences in the Activation of the Mitochondrial Permeability Transition Among Brain Regions in the Rat Correlate with Selective Vulnerability , 1999, Journal of neurochemistry.

[88]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[89]  D. Cory-Slechta,et al.  Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss , 1999, Brain Research.

[90]  W. Markesbery,et al.  Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease , 1998, Journal of neurochemistry.

[91]  M. Michaelis,et al.  Age-related decrease in brain synaptic membrane Ca2+-ATPase in F344/BNF1 rats , 1998, Neurobiology of Aging.

[92]  E. Klann,et al.  Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. , 1998, Journal of neurophysiology.

[93]  M. Berridge Neuronal Calcium Signaling , 1998, Neuron.

[94]  D. Clapham,et al.  NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation , 1998, Nature Neuroscience.

[95]  T. Montine,et al.  Distribution of Reducible 4‐Hydroxynonenal Adduct Immunoreactivity in Alzheimer Disease is Associated with APOE Genotype , 1998, Journal of neuropathology and experimental neurology.

[96]  J. Denu,et al.  Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.

[97]  E. Mackenzie,et al.  Selective Neuronal Vulnerability and Specific Glial Reactions in Hippocampal and Neocortical Organotypic Cultures Submitted to Ischemia , 1998, Experimental Neurology.

[98]  J. Sweatt,et al.  A Role for Superoxide in Protein Kinase C Activation and Induction of Long-term Potentiation* , 1998, The Journal of Biological Chemistry.

[99]  E. Gahtan,et al.  Reversible impairment of long‐term potentiation in transgenic Cu/Zn‐SOD mice , 1998, The European journal of neuroscience.

[100]  J. Vornov,et al.  Regional Vulnerability to Endogenous and Exogenous Oxidative Stress in Organotypic Hippocampal Culture , 1998, Experimental Neurology.

[101]  A. Verkhratsky,et al.  Calcium and neuronal ageing , 1998, Trends in Neurosciences.

[102]  Y. Ishikawa,et al.  Production of Reactive Oxygen Species and Release of l‐Glutamate During Superoxide Anion‐Induced Cell Death of Cerebellar Granule Neurons , 1998, Journal of neurochemistry.

[103]  R. Schmidt,et al.  Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia , 1997, Brain Research.

[104]  M Matsuo,et al.  [Oxidative stress and aging]. , 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[105]  F. Iannotti,et al.  Differential Vulnerability of the CA1 and CA3 Subfields of the Hippocampus to Superoxide and Hydroxyl Radicals In Vitro , 1997, Journal of neurochemistry.

[106]  J. David Sweatt,et al.  A Requirement for the Mitogen-activated Protein Kinase Cascade in Hippocampal Long Term Potentiation* , 1997, The Journal of Biological Chemistry.

[107]  K. Chen,et al.  Calcium Channel Density and Hippocampal Cell Death with Age in Long-Term Culture , 1997, The Journal of Neuroscience.

[108]  G. Mathern,et al.  Human Fascia Dentata Anatomy and Hippocampal Neuron Densities Differ Depending on the Epileptic Syndrome and Age at First Seizure , 1997, Journal of neuropathology and experimental neurology.

[109]  D. German,et al.  Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[110]  D. German,et al.  Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28k and calretinin , 1996, Neuroscience.

[111]  M. Michaelis,et al.  Decreased plasma membrane calcium transport activity in aging brain. , 1996, Life sciences.

[112]  A. Martínez-Serrano,et al.  Cytosolic and mitochondrial calcium in synaptosomes during aging. , 1996, Life sciences.

[113]  Philip W. Landfield,et al.  Increase in Single L-Type Calcium Channels in Hippocampal Neurons During Aging , 1996, Science.

[114]  Lucien T. Thompson,et al.  Age-related loss of calcium binding proteins in rabbit hippocampus , 1996, Neurobiology of Aging.

[115]  A. Hühmer,et al.  Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca‐ATPase of rat skeletal muscle during aging: a peroxynitrite‐mediated process? , 1996, FEBS letters.

[116]  M. O’Banion,et al.  Regional neuronal loss in aging and Alzheimer's disease: a brief review , 1994 .

[117]  H. Monyer,et al.  NMDA receptor channels: Subunit-specific potentiation by reducing agents , 1994, Neuron.

[118]  J. Disterhoft,et al.  Nimodipine decreases calcium action potentials in rabbit hippocampal CA1 neurons in an age‐dependent and concentration‐dependent manner , 1994, Hippocampus.

[119]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[120]  R. Schmidt,et al.  Effect of diabetes and aging on human sympathetic autonomic ganglia. , 1993, The American journal of pathology.

[121]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[122]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[123]  P. Mazzarello,et al.  DNA repair mechanisms in neurological diseases: facts and hypotheses , 1992, Journal of the Neurological Sciences.

[124]  G. Kreutzberg,et al.  Cytotoxicity of microglia , 1992, Journal of Neuroimmunology.

[125]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[126]  B. A. Brooks,et al.  Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a , 1992, Annals of the New York Academy of Sciences.

[127]  A. Graybiel,et al.  Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[128]  A. Martínez-Serrano,et al.  Calcium binding to the cytosol and calcium extrusion mechanisms in intact synaptosomes and their alterations with aging. , 1992, The Journal of biological chemistry.

[129]  M. Michaelis,et al.  Regulation of calcium levels in brain tissue from adult and aged rats , 1992, Mechanisms of Ageing and Development.

[130]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[131]  J. Krieglstein,et al.  Calbindin‐D28K and ischemic damage of pyramidal cells in rat hippocampus , 1992, Journal of neuroscience research.

[132]  J. Sarvey,et al.  Free radicals accelerate the decay of long-term potentiation in field CA1 of guinea-pig hippocampus , 1991, Neuroscience.

[133]  R. Schmidt-Kastner,et al.  Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.

[134]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[135]  M. Mattson,et al.  Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons , 1991, Neuron.

[136]  P. Mcgeer,et al.  Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.

[137]  J. E. Franck,et al.  Glutamate-mediated selective vulnerability to ischemia is present in organotypic cultures of hippocampus , 1990, Neuroscience Letters.

[138]  K. Takeshige,et al.  1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. , 1990, Biochemical and biophysical research communications.

[139]  J. Olney,et al.  Excitotoxicity of l-DOPA and 6-OH-DOPA: Implications for Parkinson's and Huntington's diseases , 1990, Experimental Neurology.

[140]  S. B. Kater,et al.  Development and selective neurodegeneration in cell cultures from different hippocampal regions , 1989, Brain Research.

[141]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[142]  D. German,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost? , 1988, Neuroscience.

[143]  C. Marsden,et al.  An immunohistochemical study of the acute and long-term effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in the marmoset , 1987, Neuroscience.

[144]  C. Colton,et al.  Production of superoxide anions by a CNS macrophage, the microglia , 1987, FEBS letters.

[145]  G. Gibson,et al.  Calcium and the aging nervous system , 1987, Neurobiology of Aging.

[146]  R. DeTeresa,et al.  Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.

[147]  J. Vitorica,et al.  Involvement of mitochondria in the age-dependent decrease in calcium uptake of rat brain synaptosomes , 1986, Brain Research.

[148]  C. Gerfen,et al.  The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[149]  R. Tarone,et al.  Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[150]  T. A. Pitler,et al.  Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. , 1984, Science.

[151]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[152]  S. Orrenius,et al.  The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. , 1982, The Journal of biological chemistry.

[153]  G. Cohen,et al.  6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate , 1973, Science.

[154]  E. Streicher Age changes in the calcium content of rat brain. , 1958, Journal of gerontology.

[155]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[156]  P. Shaw,et al.  Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis , 2009, Journal of Neurology.

[157]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[158]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[159]  C. Marsden,et al.  Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease , 2005, Journal of Neural Transmission.

[160]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[161]  Henry Jay Forman,et al.  Redox signaling , 2004, Molecular and Cellular Biochemistry.

[162]  M. Beal,et al.  Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[163]  Alcino J. Silva,et al.  Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. , 2003, Journal of neurobiology.

[164]  A. Sarnowska Application of organotypic hippocampal culture for study of selective neuronal death. , 2002, Folia neuropathologica.

[165]  Dean P. Jones Redox potential of GSH/GSSG couple: assay and biological significance. , 2002, Methods in enzymology.

[166]  A. Tortiglione,et al.  Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation , 2001, Journal of neuroscience research.

[167]  T. Rammsayer,et al.  Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. , 2001, Learning & memory.

[168]  J. Hirrlinger,et al.  Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. , 2000, European journal of biochemistry.

[169]  M. Rice,et al.  Mechanisms underlying H(2)O(2)-mediated inhibition of synaptic transmission in rat hippocampal slices. , 2000, Brain research.

[170]  C. DeCarli,et al.  NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. , 2000, Neurobiology of aging.

[171]  A. Raina,et al.  Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. , 1999, Redox report : communications in free radical research.

[172]  H. Hung,et al.  MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. , 1998, Free radical biology & medicine.

[173]  H. Forman,et al.  Oxidants as stimulators of signal transduction. , 1997, Free radical biology & medicine.

[174]  M. Portolés,et al.  Loss of granule neurons in the aging human cerebellar cortex. , 1996, The International journal of developmental biology.

[175]  M. Bear,et al.  Long-term depression in hippocampus. , 1996, Annual review of neuroscience.

[176]  M. Graeber,et al.  Surveillance, intervention and cytotoxicity: is there a protective role of microglia? , 1994, Developmental neuroscience.

[177]  C. Marsden,et al.  Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.

[178]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[179]  L. Fagni,et al.  The action of hydrogen peroxide on paired pulse and long-term potentiation in the hippocampus. , 1989, Free radical biology & medicine.

[180]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .